drugset / Trial / NCT00561704

Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

NCT00561704

Parallel-groupOpen-labelTreatment

Summary

Insulin resistance typically characterizes type 2 diabetes (T2DM) and prediabetic states and is the prominent feature of the metabolic syndrome.Adiponectin plays an important part in glucose metabolism,insulin resistance, the deterioration of renal function.we hypothesize there is a difference serum adiponectin levels between obese and non-obese women with type 2 diabetic nephropathy. Furthermore, these two groups would respond difference to the RAs blocker(Losartan).

Timeline

Start
2007-04
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 100 mg